Investments and investor services
Footsie hits the gas
Shell and InterContinental Hotels were the stand-out stocks on a busy day for trading updates from Footsie firms
Company
AstraZeneca PLC
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1084 stories · page 54 of 55
Investments and investor services
Rising heavyweight stocks drive up London shares
Royal Dutch Shell and AstraZeneca haul Footsie higher
UPDATE - AstraZeneca expects new products to see off generics
On a constant currency basis, Astra did better. Sales were up 1% and by 2% in the second quarter.
Investments and investor services
London market rides crest of corporate results wave
Shares rise modestly as blue-chips flood market with updates
FTSE100 keeps going well, keeps going Shell
The Anglo-Dutch index heavyweight fuelled gains for the Footsie
Archive
Thursday's agenda - More big cap results, including Rolls and BT
More results today on offer with some more big caps showing how much they are contributing to the UK's current growth trajectory. Lets start with a British stalwart - engineer Rolls Royce which posts second quarter earnings. It's been a tor
Investments and investor services
Week Ahead: Big oil and the banks to dominate
No shortage of big names reporting this week, including the state-controlled lenders Lloyds and RBS, plus integrated oil giants BP and Shell
Clinigen's strategy sees 45% revenue growth in year gone
Pharma and services specialist Clinigen said its year gone had been another "tremendous one", which saw significant organic growth and a revenue rise of more than 45%.
Celgene makes $7.2bn bid for Receptos
Celgene could face battle for Receptos, broker says
Archive
FTSE100 closes higher as all eyes still on Athens
FTSE100 closed positively but just 15 points ahead as traders considered Greece...
London shares fall as traders eye uphill Greek recovery battle
BoE's Carney points to 'big execution risks' in Greek deal.
AstraZeneca wins US approval for cancer drug
US regulators give green light to Iressa treatment for lung cancer
Archive
FTSE100 finishes higher with Greece and BP in the mix
The UK benchmark closed over 21 points to the good at 6,630, with BP top dog, with its shares adding 4.69% to 438.80p.
Archive
London shares edge higher on construction industry cheer
Building industry data help to build trader confidence despite Greece
Shell's a standout opportunity in ‘horrible and trapped’ sector
Shell, BG, and Astrazeneca are among the blue-chips under Thursday's broker spotlight
Archive
Footsie treads water as delays in solving Greek debt saga weigh
Eurogroup rules out more talks with Athens until after referendum
Cancer drug firms to cash in on $9bn immunotherapy market
Trials have shown that immunotherapy may revolutionise cancer treatment
AstraZeneca "to miss out on US drug deal" - sources
Receptos is said to have rebuffed $200 per share bid approach from AstraZeneca